| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,304 |
1,963 |
$178K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,061 |
820 |
$83K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,013 |
964 |
$69K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,938 |
1,748 |
$50K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
548 |
339 |
$13K |
| 80306 |
|
649 |
386 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,087 |
1,713 |
$4K |
| 80053 |
Comprehensive metabolic panel |
1,662 |
1,430 |
$3K |
| 87276 |
|
537 |
519 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,010 |
2,302 |
$2K |
| 87275 |
|
537 |
519 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
407 |
382 |
$1K |
| 87430 |
|
300 |
279 |
$924.54 |
| 71045 |
Radiologic examination, chest; single view |
419 |
321 |
$870.39 |
| 86710 |
|
111 |
35 |
$596.00 |
| 83735 |
|
216 |
199 |
$549.36 |
| 84484 |
|
70 |
64 |
$434.50 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
61 |
55 |
$339.68 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
220 |
156 |
$305.86 |
| 81001 |
|
792 |
714 |
$295.07 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
41 |
39 |
$82.26 |
| 87420 |
|
20 |
19 |
$24.30 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
31 |
$13.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
99 |
94 |
$6.00 |
| 36000 |
|
14 |
13 |
$0.00 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16 |
16 |
$0.00 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
32 |
18 |
$0.00 |